Translating glutamate: from pathophysiology to treatment. - Test2 - elhamkhani - TriplyDB

Translating glutamate: from pathophysiology to treatment.

Translating glutamate: from pathophysiology to treatment.

http://www.wikidata.org/entity/Q35739457

about

Auditory dysfunction in schizophrenia: integrating clinical and basic features.Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling The cytokine model of schizophrenia: emerging therapeutic strategies Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date Independent and additive effects of glutamic acid and methionine on yeast longevity Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia Neural Substrates of Auditory Emotion Recognition Deficits in Schizophrenia.Neurophysiological models for new treatment development in schizophrenia: early sensory approaches.Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc⁻ activity in the medial prefrontal cortex.Convergent findings for abnormalities of the NF-κB signaling pathway in schizophrenia.Neuromapping techniques in drug discovery: pharmacological MRI for the assessment of novel antipsychotics.Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models.Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome.Intracranial self-stimulation to evaluate abuse potential of drugs.Electrical synapses and their functional interactions with chemical synapses.Neuroprotective effect of penehyclidine hydrochloride on focal cerebral ischemia-reperfusion injury.Hampered long-term depression and thin spine loss in the nucleus accumbens of ethanol-dependent rats Future directions for research in autism spectrum disorders.Transcranial magnetic stimulation in the treatment of substance addiction Behavioral assessment of acute inhibition of system xc (-) in rats Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons.A Double-Blind, Placebo-Controlled Comparator Study of LY2140023 monohydrate in patients with schizophrenia Effects of (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline on glutamate transporter 1 and cysteine/glutamate exchanger as well as ethanol drinking behavior in male, alcohol-preferring rats.Genome-wide gene pathway analysis of psychotic illness symptom dimensions based on a new schizophrenia-specific model of the OPCRIT The N-methyl-D-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: a longitudinal mismatch negativity study R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome.Chronic Cigarette Smoking in Healthy Middle-Aged Individuals Is Associated With Decreased Regional Brain N-acetylaspartate and Glutamate Levels.Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence.Variable prenatal stress results in impairments of sustained attention and inhibitory response control in a 5-choice serial reaction time task in rats.Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy.Pituitary Adenylate cyclase-activating polypeptide orchestrates neuronal regulation of the astrocytic glutamate-releasing mechanism system xc (.).Posteromedial cortex glutamate and GABA predict intrinsic functional connectivity of the default mode network

P2860

Q26796401-D4237152-F9A5-44CC-837D-A84444B2E495 Q26830533-115E0A51-1AC8-446A-A50B-6F72C47DCB7D Q26864995-44EA6B0B-F788-4619-BA6A-52E886B3B740 Q26865996-73737B77-4090-4EA0-99C4-DC60CC902F16 Q27004490-2629F1D9-89C7-4FEB-8442-6D89348C8445 Q27025683-10109C44-341A-4552-ABEA-1C2275E021E1 Q27937541-7EBDAF53-E4B9-46F3-B374-059BACE2F85B Q28275290-E8FF2C4F-CF07-43C8-BE92-F09211F508A5 Q30384219-55894735-ECC9-4C48-AF59-5902D5AA17E0 Q30384452-09E58F27-1F18-43CD-8A8B-F093D4B839D4 Q30440988-31DE27E4-9EE0-4E29-80FA-656CD7CB3FFD Q30443697-5A11A527-BFAC-48E9-960E-7706AEFC75AE Q30564474-F14001D4-58BF-4DB7-8971-7D0C287FCDDD Q30685335-B2D22034-32F2-4954-B844-D05375EBC6CB Q30732395-00F6D7C6-6C48-414F-8C82-593BF7CD5E81 Q33574936-41676767-054E-46D3-9F6D-70F6DCFA5466 Q33647885-A88A7874-FD21-4CA8-AFBD-CC1315DD6FA3 Q33775794-452C8B29-B278-46C0-B60D-E13AC3213C27 Q33845750-23DBD71E-AA99-43AC-B1A0-EA13C4BE197E Q33881841-6DC8BD37-026B-46BB-ACEF-98AECC4649E6 Q34094903-32535BAB-3CC6-4E94-8183-02FCACB2E5C6 Q34144592-05378853-3648-4EEE-A004-02E25C592051 Q34180429-BB85436A-64A1-4F48-B3B5-59E32FE571AB Q34388951-11DB75AB-0C9E-4893-8D31-3B752D6574C6 Q34420036-A4042FAD-F343-48B0-A557-746B9072E13C Q34559591-82EA3E60-12B5-4679-975D-8AB471971F9E Q34675038-901C5D7C-28F0-4E9A-9204-63221A31BB67 Q34770351-0209301B-19C8-41EC-B9A3-0B057FD3CA34 Q35417634-BB99028B-F92D-4AE1-8F70-B93519D54981 Q35537274-93E11182-0C04-4F7A-8144-38C0696F91C2 Q35626959-FF416A5F-2105-4E60-AEDB-740C51B4972A Q36077206-0D412CD4-A4C7-4445-BEF1-EAE1E453DE77 Q36143156-548E8E30-7416-4010-9768-E58828C66CE3 Q36189837-24FEB0AF-F9F0-4767-9C62-9DB9DAFC2958 Q36234288-795095D1-3868-474A-A22E-80D730433F29 Q36448887-898BEEF6-66D2-4319-AC4F-413CA446E676 Q36477821-5FDDA0E5-BDA8-46CD-BDA0-E7AC2CA09F66 Q36798980-E08B3400-6584-451E-82A4-C45D438F6BEB Q36930072-00CAA042-F36B-4C89-965D-338703911DA7 Q37241069-AF55719A-D98E-4C14-B325-5AB6CB4AB5C7

P2860

Translating glutamate: from pathophysiology to treatment.

http://www.wikidata.org/entity/Q35739457

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Translating glutamate: from pathophysiology to treatment.

@ast

Translating glutamate: from pathophysiology to treatment.

@en

type

label

Translating glutamate: from pathophysiology to treatment.

@ast

Translating glutamate: from pathophysiology to treatment.

@en

prefLabel

Translating glutamate: from pathophysiology to treatment.

@ast

Translating glutamate: from pathophysiology to treatment.

@en

P1433

Q35739457-7F3FECAB-9360-4660-9D61-67A5A77D1B8F

P1476

Q35739457-592C5446-4742-4DB8-B2A1-4CB99333D157

P2093

Q35739457-061BA05C-F030-4BC7-A945-BC72159FBDB9

Q35739457-2832AC9A-5D2D-467F-9443-B5A94B0BD33D

Q35739457-5AA9497F-55E6-4AAF-B2F8-AB417E37BA9F

Q35739457-695CA30B-46AE-466A-AB99-4E7F6696D6EF

Q35739457-6C109D57-64C2-4059-98B6-6B9E2320510E

Q35739457-B546DEBB-6544-4ED8-A39F-B74B0633EFB1

Q35739457-C07785E9-AA5D-432B-8170-2FBC71BC99CB

Q35739457-D478364C-CB70-42A4-8DF5-6FA14E7B51A3

Q35739457-E1EAA539-B544-4608-82D3-B5F3134C8128

Q35739457-F8143DA1-4406-4309-B163-2A03DEF0B4F2

P2860

Q35739457-0014D75B-6B11-485F-98A8-55E7AA667489

Q35739457-007D10BD-FCB3-4827-9BBD-FE32B190E9D7

Q35739457-00EC8C10-C203-4672-8A4C-9257DFEBEA8A

Q35739457-0144501C-B8B5-4ABB-BC67-AC5BDEDF7852

Q35739457-02B8AE2C-2BCA-4ABB-BE60-185F69F5FEEF

Q35739457-07129EFC-50F6-47A3-A9EE-1E9FC2B3003D

Q35739457-07B92A53-5C04-45F5-A7AB-4B7774488F17

Q35739457-081F81D3-155D-422C-9FDA-A74758037FF8

Q35739457-0CA29F08-D3FC-42E0-A548-7B59E3B34D8B

Q35739457-0DFF7830-4F24-4973-9073-F6EC820C770C

P304

Q35739457-FCF4259E-0AF9-4057-98D8-FDC3B7E46308

P31

Q35739457-3CF6521A-7AFA-426C-80F1-ED9CA2769022

P356

Q35739457-A055217F-5503-4F35-91A6-CE980EDF39DF

P407

Q35739457-E3476732-B9A0-4EF2-AF4C-6A3AFDEF6AF9

P433

Q35739457-1016C5CA-3085-4CA2-9BB2-22BDBF3C2DE0

P478

Q35739457-9BC036F9-FD15-4D65-B7F4-E67557442156

P50

Q35739457-2924F5F8-5019-4B47-9C78-0BC51200C3CD

P577

Q35739457-F6FD158E-6D79-4B00-80F6-4A263698B40D

P5875

Q35739457-411625AB-29EC-400B-BEEA-02742D33BDD8

P698

Q35739457-0DBBD020-0829-4ECD-8A0E-949303118EA4

P921

Q35739457-191871C3-B9F0-493B-A1DC-D2332B7A0D91

P932

Q35739457-8CA03FA8-6347-4108-84CA-131FCBDF32A3

P356

SCITRANSLMED.3002804

P1433

Science Translational Medicine

P1476

Translating glutamate: from pathophysiology to treatment.

@en

P2093

Carlos Zarate

http://www.w3.org/2001/XMLSchema#string

Chi-Ming Lee

http://www.w3.org/2001/XMLSchema#string

Daniel Umbricht

http://www.w3.org/2001/XMLSchema#string

Darryle Schoepp

http://www.w3.org/2001/XMLSchema#string

Kalpana Merchant

http://www.w3.org/2001/XMLSchema#string

Mark F Bear

http://www.w3.org/2001/XMLSchema#string

Mihaly Hajos

http://www.w3.org/2001/XMLSchema#string

Nora D Volkow

http://www.w3.org/2001/XMLSchema#string

Peter W Kalivas

http://www.w3.org/2001/XMLSchema#string

William Z Potter

http://www.w3.org/2001/XMLSchema#string

P2860

The Autistic Neuron: Troubled Translation?

A randomized experimental investigation of reasoning training for people with delusions

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly

GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia

Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking

Reduced dendritic spine density in auditory cortex of subjects with schizophrenia

Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients

Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

P304

102mr2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3002804

http://www.w3.org/2001/XMLSchema#string

P407

P433

102

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Daniel C Javitt

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51679580

http://www.w3.org/2001/XMLSchema#string

P698

21957170

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

3273336

http://www.w3.org/2001/XMLSchema#string